News

COVID shots should target newer strains of JN.1 variant, US FDA advisers say
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
pharmaphorum2d
FDA tightens heart tox warnings on mRNA COVID vaccines
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and, in most cases, resolve within a ...
BioPharma Dive4d
Novavax’s COVID vaccine gets FDA approval, but with limits
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
BioSpace2d
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
The FDA’s independent advisors found Pfizer’s data lacked the precision needed to establish the efficacy of Talzenna in ...
STAT2d
How do we know mRNA vaccines are safe and effective? An explainer
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
BioPharma Dive2d
Moderna pulls application for combo COVID, flu shot
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny
The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to ...